MICHAEL MCNELLIS: Open Payments
NPI 1932844636 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 19 payments from 10 companies in 2025. Trend: 2023 $202 · 2024 $545 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| Lilly USA, LLC | 4 | $68 |
| ABBVIE INC. | 3 | $56 |
| Amgen Inc. | 2 | $42 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Teleflex LLC | 1 | $17 |
| Abbott Laboratories | 1 | $14 |
Products named: MOUNJARO, EVENITY, UBRELVY, Wegovy, THINPREP 2000 PROCESSOR, REXULTI, Leqembi, Kerendia.
Industry payments across KS — which companies pay providers there.
